Peptide Therapeutics Market Will Witness Growth Based On hybrid method of synthesis of peptides Till 2020:Grand View Research,inc.

Short chains of amino acid monomers which are linked by amide bonds are termed as peptides. Peptides are different from proteins due to difference in their sizes. Peptides contain less than 50 molecules of amino acids. Peptides bind themselves to some specific cell surface receptors and imitate like receptor ligands. This characteristic of peptides helps in treating various diseases as peptides act on the cell membrane. Increasing number of cancer patients and various metabolic diseases as well as technological advancements such as introduction of hybrid method of synthesis of peptides, are expected to drive the peptide therapeutics market over the forecast period. 

Huge market potential has been identified in peptide therapeutics market globally and thus various pharmaceutical and biotechnology industries are actively investing in research & development activities to develop newer peptides to be used for various applications. Cancer has been a major cause of death globally. According to world health organisation (WHO), number of cancer patients is expected to increase from 12.7 million per year in 2011 to 16 million per year in 2020.

Browse full research report on Peptide Therapeutics Market: http://www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market

Increase in metabolic diseases such as diabetes, along with increase in number of cancer patients is expected to boost the market for peptide therapeutics. Continuous R&D in peptide therapeutics has developed various technologies and routes of administration of peptides. However, the conventional route of administration which is parenteral route has grabbed maximum share in terms of revenue of total market share of peptides by route of administration in 2013. 

Technology market was dominated by long phase peptide synthesis (SPSS) of total market share in 2013. Peptide therapeutics market can be classifies on the basis of technology used, application, route of administration and product of peptides. North America holds largest market share while Asia Pacific region is expected to grow at a significant rate over next six years. Key market participants for this market include Roche, Novo-Nordisk, Bachem, Lonza, Eli Lilly, Amylin, Ipsen, Polypeptide Group, Peptisyntha etc.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

Key technology segments analysed in this report include solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS) and hybrid phase peptide synthesis (HPSS). SPSS technology segment dominated the overall peptide therapeutics market in terms of revenue in 2013. Due to introduction of newer technologies like HPSS, market share of SPSS is expected to reduce by 2020. HPSS is the fastest growing technological segment over the forecast period.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com